Status:
UNKNOWN
Lateral Ridge Augmentation Using a Volume Maintaining Collagen Scaffold Versus Allograft With Collagen Membrane.
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Alveolar Ridge Augmentation, Dental Implants
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The aim of the current study is to compare lateral bone augmentation using the current gold standard (FDBA plus resorbable collagen membrane) versus Ossix Volumax as a stand-alone material.
Detailed Description
One of the major problems in implant therapy is the need to regenerate bone after its resorption because of periodontal disease, traumatic extraction or surgical removal associated with treatment of i...
Eligibility Criteria
Inclusion
- Patients age 18 to 85 years of age.
- Alveolar ridge atrophy (\<5 mm) in the horizontal dimension requiring bone augmentation.
- Implant therapy is scheduled for this site.
- Willing to participate in the study and follow all the post-op visits.
Exclusion
- Systemic condition requiring prophylactic antibiotics.
- The Introduction( I.V.) use of medication related osteonecrosis of the jaw ( MRONJ) or the use of such medication Per Os (P.O.) for five or more years, patients with at least three month drug holiday with a C-terminal cross-linking telopeptide (CTX) \> 150 pg/ml are eligible.
- The use of medication known to impair healing (clinician desecration).
- Unable to place implant for whatever reason.
Key Trial Info
Start Date :
November 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03457298
Start Date
November 7 2018
End Date
July 1 2020
Last Update
May 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus, Dept. of Periodontology
Haifa, Israel, 31096